Injective introduces pre-IPO perpetuals, offering a new trading avenue
- Injective has launched onchain pre-IPO perpetuals for companies like OpenAI.
- The new derivatives provide leveraged exposure to private equity markets.
- This launch positions Injective as a decentralized alternative to Robinhood’s private equity tokens.
- Users can trade these perpetuals directly on the blockchain, enhancing transparency and accessibility.
The introduction of pre-IPO perpetuals by Injective marks a significant shift in how investors can access private equity markets. This development aims to democratize investment opportunities and compete with traditional platforms like Robinhood.
With the launch of these derivatives, Injective is set to reshape trading dynamics, providing users with innovative financial products that enhance market participation. (Source)
